Atlas Trials

An Investigator-initiated Study of Apremilast to Demonstrate Efficacy Nummular Eczema

Clinical trial NCT03160248 · COMPLETED

Trial details

NCT number
NCT03160248
Sponsor
Technical University of Munich
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Nummular EczemaEczemaDermatitis EczemaNummular Dermatitis
Start date
2017-07-05
Primary completion
2021-09-15
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.